Ionis Pharmaceuticals (IONS) PT Lowered to $65 at RBC Capital After Tominersen Phase III Study was Discontinued
Go back to Ionis Pharmaceuticals (IONS) PT Lowered to $65 at RBC Capital After Tominersen Phase III Study was Discontinued| (NASDAQ: IONS) | Delayed: 57.24 +1.37 (2.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.87 | 52 Week High | $62.68 | |||
| Open | $55.16 | 52 Week Low | $19.59 | |||
| Day High | $57.24 | P/E | N/A | |||
| Day Low | $55.16 | EPS | $0.00 | |||
| Volume | 1,353,738 | |||||
| UNIQURE (NASDAQ: QURE) | Delayed: 48.62 +1.56 (3.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $47.06 | 52 Week High | $22.79 | |||
| Open | $47.06 | 52 Week Low | $6.63 | |||
| Day High | $48.70 | P/E | N/A | |||
| Day Low | $46.31 | EPS | $0.00 | |||
| Volume | 957,689 | |||||
| (NASDAQ: WVE) | Delayed: 5.41 +0.21 (4.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.20 | 52 Week High | $38.50 | |||
| Open | $5.16 | 52 Week Low | $8.95 | |||
| Day High | $5.42 | P/E | N/A | |||
| Day Low | $5.14 | EPS | $0.00 | |||
| Volume | 2,884,323 | |||||

